Core Viewpoint - The company Sifang Optoelectronics has recently invested in Changhe Biotechnology, which specializes in the efficient capture, on-site detection, and intelligent monitoring of environmental pathogenic microorganisms. However, it currently does not have a specific detection solution for Nipah virus [1]. Group 1 - Changhe Biotechnology is focused on high-tech solutions for monitoring infectious diseases, including human-to-human transmission diseases [1]. - The company has developed rapid detection and monitoring products based on efficient bio-aerosol collection and nucleic acid amplification technology [1]. - These solutions allow for on-site analysis and risk warning of common zoonotic pathogens, enabling timely prevention and control of potential transmission risks [1].

Group 1 - The core viewpoint of the article is that Sifang Optoelectronics has indicated that Changhe Biology currently does not have a dedicated testing solution for Nipah virus [2] - Changhe Biology has successfully developed rapid detection and monitoring products based on efficient bio-aerosol enrichment and nucleic acid amplification technology [2] - The developed solutions allow for on-site analysis and risk warning of common zoonotic pathogens, enabling timely prevention and control of potential transmission risks [2]